Tekla Capital Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-35,743
| Closed | -$1.72M | – | 228 |
|
|
2020
Q1 | $1.72M | Sell |
35,743
-20,086
| -36% | -$934K | 0.08% | 144 |
|
|
2019
Q4 | $2.62M | Hold |
55,829
| – | – | 0.1% | 140 |
|
|
2019
Q3 | $1.32M | Buy |
55,829
+36,639
| +191% | +$1.09M | 0.06% | 147 |
|
|
2019
Q2 | $577K | Buy |
+19,190
| New | +$440K | 0.02% | 179 |
|
|
2018
Q3 | – | Sell |
-219,952
| Closed | -$2.19M | – | 216 |
|
|
2018
Q2 | $2.19M | Sell |
219,952
-118,613
| -35% | -$819K | 0.08% | 134 |
|
|
2018
Q1 | $1.8M | Sell |
338,565
-17,672
| -5% | -$126K | 0.07% | 142 |
|
|
2017
Q4 | $3.03M | Sell |
356,237
-39,581
| -10% | -$487K | 0.12% | 109 |
|
|
2017
Q3 | $5.78M | Hold |
395,818
| – | – | 0.21% | 82 |
|
|
2017
Q2 | $7.42M | Buy |
+395,818
| New | +$8.93M | 0.27% | 70 |
|
